To provide evidence based prospectives of the potential benefit effects of paricalcitol, an
analog of vitamin D, over the prevention / retardation of the progression of neoangiogenesis
(vessels), atherosclerosis and vascular calcification.
Phase:
Phase 4
Details
Lead Sponsor:
Effice Servicios Para la Investigacion S.L.
Collaborators:
Fundació Renal Jaume Arnó Jaume Arnó Renal Foundation